IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $12,191,000 | -26.0% | 468,538 | -10.0% | 0.40% | -30.2% |
| Q1 2021 | $16,482,000 | +31.0% | 520,595 | +92.0% | 0.57% | +28.3% |
| Q4 2020 | $12,578,000 | +40.9% | 271,073 | 0.0% | 0.44% | +32.3% |
| Q3 2020 | $8,924,000 | +19.9% | 271,073 | 0.0% | 0.33% | +18.0% |
| Q2 2020 | $7,441,000 | +12.4% | 271,073 | +22.6% | 0.28% | -5.4% |
| Q1 2020 | $6,618,000 | -1.8% | 221,073 | -9.2% | 0.30% | +17.3% |
| Q4 2019 | $6,740,000 | +111.6% | 243,483 | +39.1% | 0.26% | +83.5% |
| Q3 2019 | $3,185,000 | -34.7% | 175,012 | -12.1% | 0.14% | -30.2% |
| Q2 2019 | $4,881,000 | +136.6% | 199,073 | -8.2% | 0.20% | +136.9% |
| Q1 2019 | $2,063,000 | +7.4% | 216,908 | 0.0% | 0.08% | +2.4% |
| Q4 2018 | $1,920,000 | -21.3% | 216,908 | 0.0% | 0.08% | -6.8% |
| Q3 2018 | $2,440,000 | +471.4% | 216,908 | +549.5% | 0.09% | +450.0% |
| Q2 2018 | $427,000 | – | 33,395 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |